Deltex Medical Share Discussion Threads

[goodgrief] 08/5/2015 09:33

Thanks GNN, pretty much my view. Though I feel NHS is an absolute basket case.

[p1nkfish] 08/5/2015 07:37

it could easily go for > 15p.

any acquirer will be buying for what the future holds not the value at the time of an acquisition.

obviously any acquirer wants to buy as cheaply as possible and therefore the vulnerable period is prior to the real growth kicking in and becoming priced in.

just mho.

[february 30th] 08/5/2015 00:42

p1nkfish,

You'd assume a buyout at just over twice the current share price. So 15p seems reasonable, in the absence of further positive news.

[casablanca4] 07/5/2015 23:14

Bought in over a year ago. This tecnologhy is a no brainer. Better outcomes and saves health care providers money. All old hat. If confidence grows and they can convince the NHS dinosaurs, this can be a good investment.

[p1nkfish] 07/5/2015 22:32

buy out looks very likely imho but not at this price.
management would be taken care of.
good for everyone.

[bypooh] 07/5/2015 17:54

gnnmartin

So there you go - I won't tell you I told you so.

For once DEMG are doing what they said wrt to the US. Some high profile hospitals, such as Brigham and Women's in Boston, are implementing. Mass Gen is part of the same system. Both are Harvard Medical School.

Additionally, they are hiring an account development manager specifically for pediatrics in the US.

Cash is king here and there will be no easy way of raising money on AIM. They seem to have realised that at last and are acting accordingly. They might even abandon the 'national roll-out' mantra if indeed they exit 2015 at a breakeven run rate and do it themselves on an as and when basis. They seem to understand a bit better the timeframe involved between initial contact and actual contract.

Of note too is that the non-exec's have all agreed to be paid in shares valued at 11p.

[gnnmartin] 07/5/2015 17:37

I went. I'm not sure I have much to report. I was particularly keen to understand how the sales of probes in the UK could fall to the extent they have if (as Ewan says) once an anaesthetist becomes converted he sticks with ODM. Ewan said that the NH pressure on hospitals had failed in its aim of coercing them into better fluid management, but probes were bought in anticipation of the increased use.

I'm not sure I'm entirely happy with that explanation, since it suggests that growth was faltering in 2013, with the apparent growth being orders for probes that were not in fact used.

I think it is too early to say with any confidence whether and when the USA will come through. Still, I am always impressed by Ewan, even if the last few years experience tempers my enthusiasm. I hold and hope.

[goodgrief] 07/5/2015 16:41

I take it nobody went to the AGM?

[february 30th] 06/5/2015 16:46

I'd guess that Deltex will get taken over pretty quickly, for around 15p. There is enough evidence that something is going on in the US to attract the attention of Edwards or a competitor to Edwards - but not enough news to generate a sufficient rise in valuation to deter predators. For example, even if Edwards don't want to use CardioQ, it is probably worth them spending $50m to remove the threat of Deltex being taken over by someone else. Today's news about the NY hospital may on the surface seem minor, but if you multiply the model through several hundred hospitals, the revenue could add up.

[mdrans1] 06/5/2015 13:40

It is in the Clinical Commissioning Groups/Hospital Trust standard contracts that they will implement IOFM in full as per the Innovation Health and Wealth report (IHW). However it would appear that many CCGs /Hospital Trusts don’t know what is in their contracts. Either they have not read them, or they have failed to make the connection between the reference to full implementation of Innovation Health and Wealth and IOFM. In response to a freedom of information request, my local Hospital Trust declared that they had not been commissioned to undertake any IOFM in 2014/15. This was despite their Clinical Commissioning Group having provided (also under FOI) a 2014/15 Service Development and Improvement plan (SDIP) in which the Hospital Trust was to implement IHW in full by 31/03/2015.

This is what the 2015/16 Standard Contract Technical Guidance has to say about what should have been done in 2014/15 :-



36.13 Providers should by now have completed implementation of the high-impact innovations set out in Innovation, Health and Wealth, Accelerating Adoption and Diffusion in the NHS. However, commissioners should continue to use SDIPs as a way of encouraging providers to make progress in adopting specific innovations to improve patient care.

This is what the NHS Standard Contract 2015/16 General Conditions says they should do in 2015/16 if they did not do what they were contracted to do last year (in 2014/15) :-




GC9 Contract Management

9.12 The Remedial Action Plan must set out:

9.12.1 actions required and which Party is responsible for completion of each action to remedy the failure in question and the date by which each action must be completed;

9.12.2 the improvements in outcomes and/or other key indicators required, the date by which each improvement must be achieved and for how long it must be maintained;

9.12.3 any agreed reasonable and proportionate financial sanctions or other consequences for any Party for failing to complete any agreed action and/or to achieve and maintain any agreed improvement (any financial sanctions applying to the Provider not to exceed in aggregate 10% of the Actual Monthly Value in any month in respect of any Remedial Action Plan).

If a Remedial Action Plan is agreed during the final Contract Year, that Remedial Action Plan may specify a date by which an action is to be completed or an improvement is to be achieved or a period for which an improvement is to be maintained falling or extending after the Expiry Date, with a view to that Remedial Action Plan being incorporated in an SDIP under a subsequent contract between one or more of the Commissioners and the Provider for delivery of services the same or substantially the same as the Services.

Don’t hold your breath.

Part of the problem might be that they got rid of the management/contract auditors who would have been able to point out where they were going wrong. Let the GPs run the show. Just tell us what the A&E waiting times are. Contract! What’s that? Never seen it, wouldn’t know where to find it. Snowed under. Us clinicians know what we are doing.

[p1nkfish] 06/5/2015 10:25

Look at PHD as I think they will win more NHS Trusts and help with efficienct procurement and their market place, with INSC for SME funding, will help in the next few years. Substantial savings possible that then become available for innovation to increase efficiency on that side too imho.

[amt] 06/5/2015 07:42

Makes you wonder where all the Money poured into the NHS is going. It seems to have reached a point where it is not investing in technologies to save Money. Evidence of that from Toumaz also. Inefficiences will just get worse and more tax payers Money will be wasted. I recall an article that mentioned that through poor procurement many hundreds of thousands were overspent on hospital gloves alone. So Deltex probably correct to move away and invest in much better run health services in other parts of the world, pity though.

[ramnik007] 06/5/2015 07:17

At least cash flow appears not to be an issue at this stage.Interesting low cost New York account. Pity it's going to take 3 years to get to 100 probes / month. Hopefully that's a pessimistic forecast.

[p1nkfish] 05/5/2015 22:59

no firm indication of Deltex spend

[p1nkfish] 05/5/2015 22:06

Casmed conf call today. Stocking order by Deltex, read it but can't now find the link.

[gavapentin] 05/5/2015 18:10

Oh dear...I just had to Google that....didn’t realise you were 13...but I guess it explains a great deal.
Move along....

[mdrans1] 05/5/2015 17:56

SOIAR Gav.

[gavapentin] 05/5/2015 17:29

mdrans1 - why do you always have to come out with such rubbish?

Pointless

[ramnik007] 05/5/2015 15:55

I just hope the U.S. Sales / new accounts is beginning to gain momentum.

[bigt20] 05/5/2015 07:14

It will be interesting to see what tomorrow (AGM. and RNS.) brings us.

[bigt20] 30/4/2015 16:16

Anyway the USA is the way to go.

[mdrans1] 29/4/2015 10:52

GDFT does not need a lifeline. It has got DEMG.

[gavapentin] 29/4/2015 09:43

As I mentioned before, GDFT has a lifeline in NELA and HQIP

Whilst that is good for other providers of GDFT, it is also good for DEMG.

Purchasing will continue thus giving some stability to price. Whether it spikes up is anyone’s guess

[bigt20] 27/4/2015 18:08

As you mentioned the AGM., here's a map for any newbies:

hxxp://www.morelondon.com/estate/map/


Laytons, 2 More London is the location - 6th May 2015. 11am.

[ramnik007] 27/4/2015 15:56

Lot of buying going on before AGM.